Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Publicaciones

  • Bielsa, S.; Panades, M. J.; Egido, R.; Rue, M.; Salud, A.; Matias-Guiu, X.; Rodriguez-Panadero, F.; Porcel, J. M.

    ACCURaCY OF PLEURaL FLUID CYTOLOGY IN MaLIGNaNT EFFUSIONS

    Anales De Medicina Interna 25 173-177. .

  • Montero-Conde, C.; Martin-Campos, J. M.; Lerma, E.; Gimenez, G.; Martinez-Guitarte, J. L.; Combalia, N.; Montaner, D.; Matias-Guiu, X.; Dopazo, J.; de Leiva, A.; Robledo, M.; Mauricio, D.

    Molecular profiling related to poor prognosis in thyroid carcinoma. Combining gene expression data and biological information.

    ONCOGENE 27 1554-1561. .

    [doi:10.1038/sj.onc.1210792]

  • Sorolla, A.; Yeramian, A.; Dolcet, X.; Perez de Santos, A. M.; Llobet, D.; Schoenenberger, J. A.; Casanova, J. M.; Soria, X.; Egido, R.; Llombart, A.; Vilella, R.; Matias-Guiu, X.; Marti, R. M.

    Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines.

    BRITISH JOURNAL OF DERMATOLOGY 158 496-504. .

    [doi:10.1111/j.1365-2133.2007.08390.x]

  • Llobet, David; Eritja, Nuria; Encinas, Mario; Sorolla, Anabel; Yeramian, Andree; Antoni Schoenenberger, Joan; Llombart-Cussacc, Antonio; Martia, Rosa M.; Matias-Guiu, Xavier; Dolcet, Xavier

    Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.

    ANTI-CANCER DRUGS 19 115-124. .

    [doi:10.1097/CAD.0b013e3282f24031]

  • Ferran, M.; Bussaglia, E.; Lazaro, C.; Matias-Guiu, X.; Pujol, R. M.

    Acral papular neuromatosis: an early manifestation of Cowden syndrome

    BRITISH JOURNAL OF DERMATOLOGY 158 174-176. .

    [doi:10.1111/j.1365-2133.2007.08237.x]

  • Huerva, V.; Velasco, A.; Sanchez, M. C.; Mateo, A. J.; Matias-Guiu, X.

    Lattice corneal dystrophy type II: clinical, pathologic, and molecular study in a Spanish family.

    EUROPEAN JOURNAL OF OPHTHALMOLOGY 17 424-429. .

  • Scaltriti, Maurizio; Rojo, Federico; Ocana, Alberto; Anido, Judit; Guzman, Marta; Cortes, Javier; Di Cosimo, Serena; Matias-Guiu, Xavier; Ramon y Cajal, Santiago; Arribas, Joaquin; Baselga, Jose

    Expression of p95HER2, a truncated form of the HER2 receptor, and response to anti-HER2 therapies in breast cancer

    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE 99 628-638. .

    [doi:10.1093/jnci/djk134]

  • Vidal, David; Matias-Guiu, Xavier; Alomar, Agustin

    Fifty-five basal cell carcinomas treated with topical imiquimod: Outcome at 5-year follow-up

    ARCH DERMATOL 143 266-268. .

    [doi:10.1001/archderm.143.2.266]

  • Velasco, Ana; Bussaglia, Elena; Pallares, Judit; Dolcet, Xavier; Llobet, David; Encinas, Mario; Llecha, Nuria; Palacios, Jose; Prat, Jaime; Matias-Guiu, Xavier

    PIK3CA gene mutations in endometrial carcinoma: correlation with PTEN and K-RAS alterations.

    HUMAN PATHOLOGY 37 1465-1472. .

    [doi:10.1016/j.humpath.2006.05.007]

  • Dolcet, Xavier; Llobet, David; Encinas, Mario; Pallares, Judit; Cabero, Albert; Schoenenberger, Joan Antoni; Comella, Joan X.; Matias-Guiu, Xavier

    Proteasome inhibitors induce death but activate NF-kappaB on endometrial carcinoma cell lines and primary culture explants.

    Journal Of Biological Chemistry 281 22118-22130. .

    [doi:10.1074/jbc.M601350200]

  • Mayorga, ME; Sanchis, D; De Santos, AMP; Velasco, A; Dolcet, X; Casanova, JM; Baradad, M; Egido, R; Pallares, J; Espurz, N; Benitez, D; Mila, J; Malvehy, J; Castel, T; Comella, JX; Matias-Guiu, X; Vilella, R; Marti, RM

    Antiproliferative effect of STI571 on cultured human cutaneous melanoma-derived cell lines.

    MELANOMA RESEARCH 16 127-135. .

    [doi:10.1097/01.cmr.0000215039.30812.9b]

  • Alvarez-Nunez, F; Bussaglia, E; Mauricio, D; Ybarra, J; Vilar, M; Lerma, E; de Leiva, A; Matias-Guju, X

    PTEN promoter methylation in sporadic thyroid carcinomas.

    Thyroid 16 17-23. .

    [doi:10.1089/thy.2006.16.17]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU